BFA
LAB icon

BlackRock Fund Advisors’s Standard BioTools LAB Stock Holding History

BlackRock Fund Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6.5M Buy
893,432
+87,534
+11% +$550K ﹤0.01% 2803
2016
Q3 		$6.46M Buy
805,898
+43,613
+6% +$401K ﹤0.01% 2723
2016
Q2 		$6.88M Buy
762,285
+12,776
+2% +$120K ﹤0.01% 2623
2016
Q1 		$6.05M Sell
749,509
-134,334
-15% -$969K ﹤0.01% 2642
2015
Q4 		$9.55M Buy
883,843
+43,833
+5% +$430K ﹤0.01% 2474
2015
Q3 		$6.81M Sell
840,010
-34,174
-4% -$538K ﹤0.01% 2604
2015
Q2 		$21.2M Buy
874,184
+1,008
+0.1% +$31.8K 0.01% 2080
2015
Q1 		$36.8M Sell
873,176
-3,099
-0.4% -$123K 0.01% 1714
2014
Q4 		$29.6M Buy
876,275
+117,302
+15% +$3.32M 0.01% 1829
2014
Q3 		$18.6M Sell
758,973
-28,018
-4% -$788K 0.01% 2002
2014
Q2 		$23.1M Buy
786,991
+11,601
+1% +$372K 0.01% 1932
2014
Q1 		$34.2M Buy
775,390
+41,521
+6% +$1.83M 0.01% 1671
2013
Q4 		$28.1M Sell
733,869
-142,571
-16% -$4.2M 0.01% 1784
2013
Q3 		$19.2M Buy
876,440
+241,243
+38% +$4.74M 0.01% 1989
2013
Q2 		$11.1M Buy
+635,197
New +$11.1M ﹤0.01% 2205

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock Fund Advisors's LAB Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Standard BioTools (LAB) stake by 11% in Q4 2016, buying an estimated $550K and bringing the position to 893,432 shares worth $6.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2803.

BlackRock Fund Advisors first reported a position in LAB in Q2 2013 and has held it in 15 quarters since. The position peaked at $36.8M in Q1 2015. 83 funds tracked by Wall St. Rank hold LAB as of Q4 2016.

  • BlackRock Fund Advisors held 893,432 shares of Standard BioTools worth $6.5M as of Q4 2016.
  • BlackRock Fund Advisors bought 87,534 Standard BioTools shares in Q4 2016, an estimated $550K.
  • Standard BioTools made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2803 holding.
  • BlackRock Fund Advisors first reported a position in Standard BioTools in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Standard BioTools position peaked at $36.8M in Q1 2015.
  • 83 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.